XML 29 R18.htm IDEA: XBRL DOCUMENT v3.8.0.1
ORGANIZATION AND BUSINESS (Details) - USD ($)
1 Months Ended 6 Months Ended
Jul. 19, 2017
Jul. 31, 2016
Jun. 27, 2016
Apr. 30, 2016
Apr. 30, 2016
Apr. 01, 2016
Dec. 31, 2010
Jul. 31, 2009
Subsequent Event [Member] | Humavox [Member]                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Percentage of interest purchased in acquisition     100.00%          
Total purchase price     $ 16,000,000          
Percentage of Company's common stock offered as consideration for acquisition     50.00%          
Period of unconditional installments     24 months          
Termination date for business acquisition agreement   Jul. 29, 2016            
Subsequent Event [Member] | Humavox [Member] | Warrants and options [Member]                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Percentage of interest purchased in acquisition     100.00%          
Subsequent Event [Member] | Humavox [Member] | First installment amount [Member]                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Total purchase price     $ 5,500,000          
Subsequent Event [Member] | Medical technology business [Member] | Scenario, Forecast [Member]                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Consideration owed for due diligence expenditures $ 100,000              
Consideration owed for additional due diligence expenditures 100,000              
Common stock issuable as consideration for business acquisition at an issue price of USD$0.22 $ 2,500,000              
Common stock issuance price per share $ 0.22              
Common stock issuable as consideration at issue price of USD$0.22 subject to the Sellers achieving sales revenue of USD$100,000 within twelve months after the first anniversary of Completion $ 2,500,000              
Common stock issuable as consideration at the issue price of USD$0.22, subject to the Sellers achieving sales revenue of USD$1,000,000 within twelve months after the first anniversary of Completion $ 2,500,000              
Issuance price per share for each milestone achieved $ 0.22              
Required capital to be raised by Company as part of acquisition agreement and as a condition to completion $ 2,500,000              
Subsequent Event [Member] | Medical technology business [Member] | Scenario, Forecast [Member] | Maximum [Member]                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Purchase price $ 7,500,000              
PayItSimple [Member]                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Investment amount           $ 15,000,000    
Percentage purchase of interest           30.00%    
Termination date for business acquisition agreement       Apr. 06, 2016        
PayItSimple [Member] | Total Interest Holding [Member]                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Percentage purchase of interest           40.00%    
PayItSimple [Member] | Additional Investment [Member]                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Investment amount           $ 7,500,000    
Percentage purchase of interest           10.00%    
Golden Target Pty Ltd, Principal Stockholder [Member]                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Percentage of entity owned       74.78% 74.78%      
Percentage of interest purchased in acquisition               96.00%
Century Thrust Joint Venture Agreement [Member] | Century Concession in Laos [Member]                
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                
Aggregate percentage owned by unrelated entity             70.00%  
Potential percentage of investee earnings attributable to Aurum if specified funding is provided by Aurum         72.86%      
Potential ownership percentage if funding is provided by Aurum         51.00%